Ubrigene

Suzhou, China · Founded 2015 · Privately Held (backing)

Provider of gene and cell therapy contract research services intended to assist drug development companies. Ubrigene is based in Suzhou, China and was founded in 2015. Its last reported valuation was $50.8 million in Dec 2020. It has raised $143 million.

Last reported valuation

$50.8M

Oct 2026

Priced at

—

Total raised

$142.9M

Last round

—

How much has Ubrigene raised?

$142.9Macross 0 recorded rounds

Free account

More of Ubrigene with a free account

·The complete investor list: 18 names
·Watch Ubrigene: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Ubrigene investors

18 investors are on record for Ubrigene, including Addor Capital, Cowin Capital, IDG Capital and Guotai Junan Innovation Investment.

For fundraisers

Raising for a company like Ubrigene?

18 investors have backed Ubrigene.

See all 18 investors →

Frequently asked about Ubrigene

How much has Ubrigene raised?: Ubrigene has raised $142.9M in total across 0 recorded funding rounds.